News
OMMH
0.0001
NaN%
--
Weekly Report: what happened at OMMH last week (0908-0912)?
Weekly Report · 09/15 11:55
Weekly Report: what happened at OMMH last week (0901-0905)?
Weekly Report · 09/08 11:57
Weekly Report: what happened at OMMH last week (0825-0829)?
Weekly Report · 09/01 11:51
Weekly Report: what happened at OMMH last week (0818-0822)?
Weekly Report · 08/25 12:06
Weekly Report: what happened at OMMH last week (0811-0815)?
Weekly Report · 08/18 11:55
Weekly Report: what happened at OMMH last week (0804-0808)?
Weekly Report · 08/11 12:05
Weekly Report: what happened at OMMH last week (0728-0801)?
Weekly Report · 08/04 12:07
Weekly Report: what happened at OMMH last week (0721-0725)?
Weekly Report · 07/28 12:08
Weekly Report: what happened at OMMH last week (0714-0718)?
Weekly Report · 07/21 11:56
Weekly Report: what happened at OMMH last week (0707-0711)?
Weekly Report · 07/14 12:08
Weekly Report: what happened at OMMH last week (0630-0704)?
Weekly Report · 07/07 11:56
Weekly Report: what happened at OMMH last week (0623-0627)?
Weekly Report · 06/30 12:05
Weekly Report: what happened at OMMH last week (0616-0620)?
Weekly Report · 06/23 11:55
Weekly Report: what happened at OMMH last week (0609-0613)?
Weekly Report · 06/16 12:04
Weekly Report: what happened at OMMH last week (0602-0606)?
Weekly Report · 06/09 12:06
Weekly Report: what happened at OMMH last week (0526-0530)?
Weekly Report · 06/02 12:18
Weekly Report: what happened at OMMH last week (0519-0523)?
Weekly Report · 05/26 12:16
Weekly Report: what happened at OMMH last week (0512-0516)?
Weekly Report · 05/19 12:04
Weekly Report: what happened at OMMH last week (0505-0509)?
Weekly Report · 05/12 12:05
Weekly Report: what happened at OMMH last week (0428-0502)?
Weekly Report · 05/05 12:08
More
Webull provides a variety of real-time OMMH stock news. You can receive the latest news about Omnimmune Hldgs Inc through multiple platforms. This information may help you make smarter investment decisions.
About OMMH
Omnimmune Holdings, Inc. (Omnimmune) is a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic and prognostic technologies. The Company is the holding company of Omnimmune Corp. Omnimmune has acquired licensed rights to diagnostic and platform monoclonal antibody technologies. Omnimmune’s hCGß and related technologies, which are protected through an expanding intellectual property portfolio, have been developed at institutions including Columbia University of New York, New York (Columbia), The Allegheny-Singer Research Institute of the West Penn Allegheny Health System, Pittsburgh, Pennsylvania (Allegheny) and The Institute Gustave Roussy, Paris, France (IGR).